explore -WSS

explore

author：focus 2025-08-12 08:27:21 - browse：4758

Illustration of miniature doctor figurines standing on a stethoscope with a roll of money to the right. — Adobe

Physician staffing firms, flailing in the wake of a federal law banning surprise bills, are demanding extra payment from hospitals to stay afloat. Hospitals, desperate for doctors to staff their facilities, have little choice but to comply.

It’s a big topic of conversation on for-profit hospital earnings calls. Just last week, major hospital chains said those expenses, known as physician subsidies, were up 20% to 40% from last year. And experts say it’s just as bad at not-for-profit hospitals. It’s a complicated problem that’s gotten worse just as contract labor expenses — hospitals’ hallmark problem of the past three years — ease up.

“This is the new contract labor,” said Whit Mayo, senior managing director with Leerink Partners. “This is the new cost issue that the industry is having to deal with.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Personalized medicine goes far beyond genetics

hotspot

WSS

Change Healthcare cyberattack outage could last weeks

Heart disease in astronauts blamed on cosmic radiation

Obesity now affects over 1 billion people worldwide, study finds

Alnylam reports growth in sales of rare disease treatments

How I helped Pfizer think through the ethics of Viagra

Congress gives doctors Medicare pay bump

entertainment

explore

explore

Anesthesiologist group: stop taking Ozempic before surgery

Personalized medicine goes far beyond genetics

Alkermes shareholders re

Florida officials tell state schools to teach AP Psychology 'in its entirety'

How one medical school became remarkably diverse

Chris Christie meets with Zelenskyy during Ukraine trip

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

Drug repurposing or repositioning? The language matters

Alnylam reports growth in sales of rare disease treatments

entertainment

Pfizer highlights cancer drugs it thinks could reignite investor interest

2 officers injured in shooting in Orlando, police say

Kenai launches with $82 million for Parkinson’s stem cell therapy

How to fix the rural physician shortage in the U.S.

H.R. 3 is the wrong path to lower drug costs

H.R. 3 is the wrong path to lower drug costs

focus

hotspot

leisure time

focus